Aeroexina Masilinus
Jump to navigation
Jump to search
 | This article is incomplete because it is pending further input from participants, or it is a work-in-progress by one author. Please comment on this article's talk page to share your input, comments and questions. Note: To contribute to this article, you may need to seek help from the author(s) of this page. |
| Aeroexina Masilinus | |
| |
| Target Pathogen | Influenza A Virus |
| Type | Vaccine |
| Company | BioLabs |
| Date First Used | January 17, 2021 |
| Type of Vaccine | mRNA |
| Booster Required | Yes (2 Weeks After first shot) |
| Cost | K/30 |
Aeroexina Masilinus (Aeroex) is a vaccine targeting the A Type Influenza Virus.